Analyst Estimates: Here's What Brokers Think Of AddLife AB (publ) (STO:ALIF B) After Its Second-Quarter Report
AddLife AB (publ) (STO:ALIF B) last week reported its latest quarterly results, which makes it a good time for investors to dive in and see if the business is performing in line with expectations. AddLife reported in line with analyst predictions, delivering revenues of kr2.7b and statutory earnings per share of kr1.06, suggesting the business is executing well and in line with its plan. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.
Taking into account the latest results, the current consensus from AddLife's three analysts is for revenues of kr10.9b in 2026. This would reflect a credible 3.6% increase on its revenue over the past 12 months. Statutory earnings per share are expected to descend 11% to kr4.39 in the same period. Before this earnings report, the analysts had been forecasting revenues of kr10.8b and earnings per share (EPS) of kr4.42 in 2026. The consensus analysts don't seem to have seen anything in these results that would have changed their view on the business, given there's been no major change to their estimates.
View our latest analysis for AddLife
The analysts reconfirmed their price target of kr198, showing that the business is executing well and in line with expectations. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. There are some variant perceptions on AddLife, with the most bullish analyst valuing it at kr205 and the most bearish at kr185 per share. Even so, with a relatively close grouping of estimates, it looks like the analysts are quite confident in their valuations, suggesting AddLife is an easy business to forecast or the the analysts are all using similar assumptions.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We can infer from the latest estimates that forecasts expect a continuation of AddLife'shistorical trends, as the 7.3% annualised revenue growth to the end of 2026 is roughly in line with the 6.6% annual growth over the past five years. Compare this with the broader industry, which analyst estimates (in aggregate) suggest will see revenues grow 7.2% annually. It's clear that while AddLife's revenue growth is expected to continue on its current trajectory, it's only expected to grow in line with the industry itself.
The Bottom Line
The most important thing to take away is that there's been no major change in sentiment, with the analysts reconfirming that the business is performing in line with their previous earnings per share estimates. Happily, there were no real changes to revenue forecasts, with the business still expected to grow in line with the overall industry. The consensus price target held steady at kr198, with the latest estimates not enough to have an impact on their price targets.
With that in mind, we wouldn't be too quick to come to a conclusion on AddLife. Long-term earnings power is much more important than next year's profits. At Simply Wall St, we have a full range of analyst estimates for AddLife going out to 2028, and you can see them free on our platform here..
You still need to take note of risks, for example - AddLife has 2 warning signs we think you should be aware of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.